Literature DB >> 5907943

Pituitary ablation for diabetic retinopathy.

J S Speakman, C B Mortimer, T D Briant, C Ezrin, W M Lougheed, W T Clarke.   

Abstract

Pituitary ablation was performed on 26 patients with advanced diabetic retinopathy by pituitary stalk section (nine patients) or transphenoidal hypophysectomy (17 patients). After a latent period varying from six to 12 months, retinal hemorrhages disappeared, vitreous hemorrhages stopped and new vessels regressed. Eight of 10 patients followed up for more than a year had a complete remission, although in one of two patients whose ablation was incomplete the retinopathy remained active. Preoperative visual acuity levels were preserved in 47 of 50 eyes of patients followed up for a mean period of 12 months. Three patients have died, two from causes related to their operation. Twenty of the survivors have continued in their usual occupation. Pituitary ablation is effective in preventing the progressive visual deterioration usually associated with advanced diabetic retinopathy.

Entities:  

Mesh:

Year:  1966        PMID: 5907943      PMCID: PMC1935379     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

1.  VISUAL PROGNOSIS OF PROLIFERATING DIABETIC RETINOPATHY.

Authors:  W P BEETHAM
Journal:  Br J Ophthalmol       Date:  1963-10       Impact factor: 4.638

2.  TREATMENT OF DIABETIC RETINOPATHY BY X-RADIATION OF THE PITUITARY.

Authors:  J A OOSTERHUIS; D H LOEWER-SIEGER
Journal:  Acta Ophthalmol (Copenh)       Date:  1963

3.  HYPOPHYSECTOMY FOR THE TREATMENT OF DIABETIC RETINOPATHY.

Authors:  O H PEARSON; B S RAY; J M MCLEAN; W L PERETZ; E GREENBERG; A PAZIANOS
Journal:  JAMA       Date:  1964-04-13       Impact factor: 56.272

4.  PROGNOSIS FOR VISION IN DIABETIC RETINOPATHY.

Authors:  F I CAIRD; C J GARRETT
Journal:  Diabetes       Date:  1963 Sep-Oct       Impact factor: 9.461

Review 5.  PITUITARY ABLATION IN THE TREATMENT OF DIABETIC RETINOPATHY.

Authors:  R F BRADLEY; S B REES; C A FAGER
Journal:  Med Clin North Am       Date:  1965-07       Impact factor: 5.456

6.  Pituitary ablation by yttrium-90 implants for diabetic retinopathy.

Authors:  R FRASER; G F JOPLIN; R E STEINER
Journal:  Diabetes       Date:  1962 Nov-Dec       Impact factor: 9.461

7.  Hypophysectomy in severe diabetes. I. Neurosurgical aspects.

Authors:  M JAVID; E S GORDON; T C ERICKSON
Journal:  J Neurosurg       Date:  1958-09       Impact factor: 5.115

  7 in total
  7 in total

1.  Pituitary ablation for diabetic retinopathy.

Authors: 
Journal:  Br Med J       Date:  1968-05-04

2.  [Anesthetic studies on trans-sphenoidal hypophysectomy: retrospective study].

Authors:  J Côté; M Rouillard
Journal:  Can Anaesth Soc J       Date:  1977-03

3.  The endocrine aspects of trans-sphenoidal hypophysectomy.

Authors:  C Ezrin; T D Briant; G Firestone; F Rosen
Journal:  Can Med Assoc J       Date:  1967-07-08       Impact factor: 8.262

Review 4.  Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Authors:  John J Kopchick; Reetobrata Basu; Darlene E Berryman; Jens O L Jorgensen; Gudmundur Johannsson; Vishwajeet Puri
Journal:  Nat Rev Endocrinol       Date:  2022-06-24       Impact factor: 47.564

5.  Pituitary Radiosurgery for Management of Intractable Pain: Tokyo Women's Medical University Experience and Literature Review.

Authors:  Mikhail F Chernov; Motohiro Hayashi
Journal:  Acta Neurochir Suppl       Date:  2021

6.  Meningitis complicating transsphenoidal hypophysectomy.

Authors:  B Romanowski; D L Tyrrell; B K Weir; G Goldsand
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

Review 7.  From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

Authors:  Jakob Triebel; Maria Ludivina Robles-Osorio; Renata Garcia-Franco; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-11       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.